Date Initiated by Firm |
January 21, 2022 |
Create Date |
March 08, 2022 |
Recall Status1 |
Open3, Classified |
Recall Number |
Z-0738-2022 |
Recall Event ID |
89675 |
Product Classification |
Reagents, 2019-novel coronavirus nucleic acid - Product Code QJR
|
Product |
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Ref # 300900 (marketed under EUA202947). Distributed in boxes of 6 assay strips in individual pouches. Box, pouch and strips all labeled with product name, ref #, lot #, and expiration date. |
Code Information |
Lot: 116305 S/L-02 (Sublot 02),UDI: 10814278020830
|
Recalling Firm/ Manufacturer |
NeuMoDx Molecular Inc 1250 Eisenhower Pl Ann Arbor MI 48108-3281
|
For Additional Information Contact |
QIAGEN Technical Services 800-362-7737
|
Manufacturer Reason for Recall |
A risk for product contamination was identified for the affected product lot. If used, there is an increased potential for SARS-CoV-2 false positive results when using the product.
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
Customers were contacted by phone 21 Jan 2022 and sent a follow up email with instructions to stop using Lot 116305 S/L02, discard remaining inventory, and review all SARS-CoV-2 positive results previously obtained using the affected product lot to exclude erroneous diagnosis and treatment. Customers are to forward this information to all individuals and departments within their organization using the affected product. If you have any questions regarding this notice, please contact QIAGEN Technical Services at 1-800-362-7737 or techservice-na@qiagen.com. |
Quantity in Commerce |
102 boxes |
Distribution |
US Nationwide distribution in the states of FL, MD, MI, NY. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|